Earnings History Data for MannKind Corporation (MNKD) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

MannKind Corporation

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		MNKD	MannKind Corporation	2,000	0.04	0.04	0.00	MannKind Non-GAAP EPS of $0.06 beats by $0.03, revenue of $70.08M misses by $4.41M [11/7/2024 4:04 PM]	7.31	-0.08 (-1.08%)	7.00	-0.39 (-5.28%)	3.17 - 7.63	4,216,678	3,030,000	43,113
MannKind Non-GAAP EPS of $0.06 beats by $0.03, revenue of $70.08M misses by $4.41M [11/7/2024 4:04 PM] MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update [2024-11-07 04:02PM] MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For [Nov-06-24 07:17AM] MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [2024-11-08 02:28AM] MannKind (MNKD) Q3 2024 Earnings Call Transcript [Nov-07-24 11:15PM] MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say [Nov-07-24 07:00PM] MannKind (MNKD) Matches Q3 Earnings Estimates [Nov-07-24 05:40PM] MannKind: Q3 Earnings Snapshot [Nov-07-24 04:34PM]
07-08-2024	PM		MNKD	MannKind Corporation	1,450	0.05	0.01	-0.02	MannKind Non-GAAP EPS of $0.05, revenue of $72.39M beats by $7.58M [8/7/2024 8:07 AM]	5.02	-0.25 (-4.74%)	5.55	0.28 (5.31%)	3.17 - 6.04	2,957,865	2,660,000	21,147
MannKind Q2 Earnings Preview [8/6/2024 12:07 PM] MannKind Non-GAAP EPS of $0.05, revenue of $72.39M beats by $7.58M [8/7/2024 8:07 AM]
08-05-2024	AH		MNKD	MannKind Corporation	1,190	0.04	0.02	-0.04	MannKind GAAP EPS of $0.04 beats by $0.01, revenue of $66.26M beats by $5.71M [5/8/2024 4:20 PM]	4.29	-0.11 (-2.39%)	4.43	0.03 (0.68%)	3.17 - 5.75	1,812,200	1,980,000	22,735
MannKind GAAP EPS of $0.04 beats by $0.01, revenue of $66.26M beats by $5.71M [5/8/2024 4:20 PM]
27-02-2024	AH		MNKD	MannKind Corporation	956.99	0.01	-0.01	-0.07	MannKind Non-GAAP EPS of $0.02 beats by $0.03, revenue of $58.47M beats by $5.33M [2/27/2024 4:01 PM]	3.89	0.11 (2.91%)	3.90	0.12 (3.17%)	3.17 - 5.75	5,766,382	2,020,000	6,213
MannKind Non-GAAP EPS of $0.02 beats by $0.03, revenue of $58.47M beats by $5.33M [2/27/2024 4:01 PM]
07-11-2023	AH		MNKD	MannKind Corporation	1,060	N/A	-0.02	-0.06	MannKind Non-GAAP EPS of $0.02 beats by $0.02, revenue of $51.25M beats by $0.53M [11/7/2023 4:01 PM]	3.65	-0.15 (-4.08%)	4.02	0.22 (5.79%)	3.62 - 5.75	3,463,909	2,590,000	23,661
MannKind Non-GAAP EPS of $0.02 beats by $0.02, revenue of $51.25M beats by $0.53M [11/7/2023 4:01 PM]
07-08-2023	AH		MNKD	MannKind Corporation	1,240	-0.02	-0.04	-0.11	MannKind Non-GAAP EPS of $0.00 beats by $0.04, revenue of $48.61M beats by $5.66M [8/7/2023 4:04 PM]	5.43	0.83 (18.15%)	4.90	0.30 (6.52%)	2.91 - 5.73	15,288,413	2,170,000	56,034
MannKind Non-GAAP EPS of $0.00 beats by $0.04, revenue of $48.61M beats by $5.66M [8/7/2023 4:04 PM]
09-05-2023	AH	After the close (May 9)	MNKD	MannKind Corporation	1,050	-0.04	-0.05	-0.10	MannKind GAAP EPS of -$0.04 beats by $0.01, revenue of $40.62M beats by $3.22M [5/9/2023 4:01 PM]	4.39	0.59 (15.66%)	4.05	0.25 (6.58%)	2.61 - 5.73	5,592,826	3,020,000	7,993
MannKind GAAP EPS of -$0.04 beats by $0.01, revenue of $40.62M beats by $3.22M [5/9/2023 4:01 PM]
23-02-2023	AH	After the close (Feb 23)	MNKD	MannKind Corporation	1,480	-0.07	-0.06	-0.11	MannKind GAAP EPS of -$0.07 misses by $0.02, revenue of $36.06M beats by $0.55M [2/23/2023 4:05 PM]	5.41	0.19 (3.64%)	5.19	-0.03 (-0.57%)	2.49 - 5.66	3,875,282	2,560,000	6,887
MannKind GAAP EPS of -$0.07 misses by $0.02, revenue of $36.06M beats by $0.55M [2/23/2023 4:05 PM]
08-11-2022	PM	8:00 AM ET (Nov 8)	MNKD	MannKind Corporation	885.24	-0.06	-0.10	-0.04	MannKind GAAP EPS of -$0.06 beats by $0.02, revenue of $32.83M beats by $7.83M [11/8/2022 8:02 AM]	3.82	0.19 (5.23%)	3.71	0.08 (2.20%)	2.49 - 5.24	3,816,157	4,190,000	11,612
MannKind GAAP EPS of -$0.06 beats by $0.02, revenue of $32.83M beats by $7.83M [11/8/2022 8:02 AM]
09-08-2022	AH	4:00 PM ET (Aug 9)	MNKD	MannKind Corporation	841.04	-0.11	-0.09	-0.05	MannKind GAAP EPS of -$0.11 misses by $0.02, revenue of $18.89M beats by $3.27M [8/9/2022 4:02 PM]	4.29	0.20 (4.77%)	4.00	-0.09 (-2.20%)	2.49 - 5.44	3,515,390	3,730,000	4,256
MannKind GAAP EPS of -$0.11 misses by $0.02, revenue of $18.89M beats by $3.27M [8/9/2022 4:02 PM] MannKind down 2% after Q2 2022 bottom line miss; however, net loss narrowed [8/9/2022 5:29 PM]
05-05-2022	AH	4:00 PM ET (May 5)	MNKD	MannKind Corporation	827.40	-0.10	-0.10	-0.05	MannKind GAAP EPS of -$0.10 in-line, revenue of $11.99M beats by $1.38M [5/5/2022 4:03 PM]	2.96	-0.11 (-3.58%)	3.06	-0.01 (-0.33%)	2.49 - 5.53	3,404,820	3,500,000	9,464
MannKind GAAP EPS of -$0.10 in-line, revenue of $11.99M beats by $1.38M [5/5/2022 4:03 PM] Regenxbio (RGNX) Reports Q1 Loss, Misses Revenue Estimates [May-04-22 06:15PM] MannKind Corporation Reports 2022 First Quarter Financial Results [May-05-22 04:00PM] MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 05:25PM] MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript [May-06-22 01:30AM]
24-02-2022	AH	4:05 PM ET (Feb 24)	MNKD	MannKind Corporation	944.72	-0.11	-0.06	-0.06	MannKind Non-GAAP EPS of -$0.11 misses by $0.05, revenue of $12.52M misses by $4.59M [2/24/2022 4:03 PM]	2.83	-0.07 (-2.58%)	2.90	-0.01 (-0.34%)	2.68 - 6.18	3,264,313	3,310,000	6,713
MannKind says FDA extends deadline to review Tyvaso DPI [2/24/2022 6:38 AM] MannKind Non-GAAP EPS of -$0.11 misses by $0.05, revenue of $12.52M misses by $4.59M [2/24/2022 4:03 PM] MannKind earnings miss on top and bottom lines, capping 20% daily loss [2/24/2022 4:57 PM] MannKind files for $50M mixed shelf offering [2/24/2022 5:44 PM] Update on Tyvaso DPI New Drug Application [Feb-24-22 06:05AM] MannKind Corporation Reports 2021 Fourth Quarter and Full Year Financial Results [Feb-24-22 04:00PM] MannKind Corporation (MNKD) Q4 2021 Earnings Call Transcript [Feb-25-22 12:30AM]
09-11-2021	AH	4:00 PM ET (Nov 9)	MNKD	MannKind Corporation	1,220	-0.04	-0.05	-0.05	MannKind EPS beats by $0.04, beats on revenue [11/9/2021 4:09 PM]	4.82	0.02 (0.31%)	5.00	0.20 (4.17%)	2.38 - 6.25	2,947,930	1,880,000	8,923
MannKind EPS beats by $0.04, beats on revenue [11/9/2021 4:09 PM] MannKind Q3 2021 net loss narrows as it beats on EPS and revenue [11/9/2021 4:35 PM] Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds [Nov-09-21 06:05AM] MannKind Corporation Reports 2021 Third Quarter Financial Results [Nov-09-21 04:05PM] MannKind (MNKD) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-21 07:55PM]
11-08-2021	AH	4:00 PM ET (Aug 11)	MNKD	MannKind Corporation	1,010	-0.05	-0.04	-0.05	MannKind EPS misses by $0.01, beats on revenue [8/11/2021 4:06 PM]	4.07	0.08 (2.01%)	3.96	-0.03 (-0.75%)	1.56 - 6.25	2,696,738	2,250,000	15,343
MannKind EPS misses by $0.01, beats on revenue [8/11/2021 4:06 PM] MannKind Corporation Reports 2021 Second Quarter Financial Results [Aug-11-21 04:00PM] MannKind (MNKD) Reports Q2 Loss, Tops Revenue Estimates [Aug-11-21 05:15PM] MannKind Corporation (MNKD) Q2 2021 Earnings Call Transcript [Aug-12-21 11:30AM]
12-05-2021	AH	4:00 PM ET (May 12)	MNKD	MannKind Corporation	1,070	-0.05	-0.04	-0.03	MannKind EPS in-line, beats on revenue [5/12/2021 4:01 PM]	4.03	0.01 (0.25%)	4.10	0.08 (1.99%)	1.14 - 6.25	2,937,307	3,140,000	5,311
MannKind EPS in-line, beats on revenue [5/12/2021 4:01 PM] MannKind's Q1 net loss widens as Afrezza revenue increases only 1% [5/12/2021 4:39 PM] MannKind Corporation to Participate in 2021 RBC Capital Markets Global Healthcare Conference [May-11-21 09:00AM] MannKind Corporation Reports 2021 First Quarter Financial Results [May-12-21 04:00PM] MannKind Corporation (MNKD) Q1 2021 Earnings Call Transcript [May-13-21 08:30AM] MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly [May-13-21 09:00AM]
25-02-2021	PM	8:00 AM ET (Feb 25)	MNKD	MannKind Corporation	1,450	-0.06	-0.03	-0.07	MannKind EPS misses by $0.01, beats on revenue [2/25/2021 8:04 AM]	5.60	-0.38 (-6.30%)	5.99	0.01 (0.17%)	0.80 - 6.25	4,663,651	5,209,936	196,720
MannKind EPS misses by $0.01, beats on revenue [2/25/2021 8:04 AM] BTIG sees bullish future for MannKind, doubles price target as shares surge [2/24/2021 11:15 AM]
04-11-2020	AH	4:00 PM ET (Nov 4)	MNKD	MannKind Corporation	458.35	-0.05	-0.04	-0.05	MannKind EPS in-line, misses on revenue [11/4/2020 4:02 PM]	2.26	0.19 (9.18%)	1.96	-0.11 (-5.31%)	0.80 - 2.48	4,891,343	2,382,731	39,000

05-08-2020	AH	4:00 PM ET (Aug 5)	MNKD	MannKind Corporation	332.49	-0.05	-0.05	-0.07	MannKind EPS in-line, beats on revenue [8/5/2020 4:03 PM]	1.66	-0.20 (-10.75%)	1.65	-0.21 (-11.29%)	0.80 - 2.48	2,806,431	2,048,684	55,155

06-05-2020	AH		MNKD	MannKind Corporation	279.20	-0.03	-0.06	-0.08		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0